BiotechTube
Home/Pipeline/Cytotoxic Oncology Generic

Cytotoxic Oncology Generic

Various Solid Tumors

Pre‑clinicalActive

Key Facts

Indication
Various Solid Tumors
Phase
Pre‑clinical
Status
Active
Company
MSN Laboratories

About MSN Laboratories

Indian pharma firm delivering affordable small‑molecule APIs, generics, and contract manufacturing services worldwide.

View full company profile

Therapeutic Areas

Infectious DiseasesOncologyBiosimilars

Other Various Solid Tumors Drugs

DrugCompanyPhase
NUC-8232NuCanaPhase 1
TCR Library ProgramMedigeneDiscovery
Guardant Infinity Biomarker DiscoveryGuardant HealthDevelopment/Commercial
APCEDEN®APAC BiotechApproved
Solid Tumor ProfilingDiatech PharmacogeneticsCommercial
BAVENCIO (avelumab)EMD SeronoApproved
FoundationOne®CDx Indication ExpansionFoundation MedicineApproved/Commercial
FoundationOne®Liquid CDx Indication ExpansionFoundation MedicineApproved/Commercial
177Lu‑BetaBart (RV‑01)AtomVie Global RadiopharmaPhase 1/2a
BeiGene Oncology PortfolioEVA PharmaPhase 2/3
Bevacizumab BiosimilarBio Usawa BiotechnologyPreclinical
PRIMO‑TB161‑001Primo BiotechnologyPreclinical